Tau kinase inhibition for treatment of Alzheimer's disease

被引：0
|
作者：
Bhat, R [1 ]
机构：
[1] AstraZeneca, Preclin DMPK, Sodertalje, Sweden
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91635-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Tau phosphorylation in Alzheimer's disease
    Hanger, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S100 - S100
  • [22] The role of tau in Alzheimer's disease
    Trojanowski, JQ
    Lee, VMY
    MEDICAL CLINICS OF NORTH AMERICA, 2002, 86 (03) : 615 - +
  • [23] Dendritic Tau in Alzheimer's Disease
    Ittner, Arne
    Ittner, Lars M.
    NEURON, 2018, 99 (01) : 13 - 27
  • [24] Aluminium, tau and Alzheimer's disease
    Exley, Christopher
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 12 (04) : 313 - 315
  • [25] The complexity of tau in Alzheimer's disease
    Naseri, Nima N.
    Wang, Hong
    Guo, Jennifer
    Sharma, Manu
    Luo, Wenjie
    NEUROSCIENCE LETTERS, 2019, 705 : 183 - 194
  • [26] Tau immunotherapies for Alzheimer's disease
    Hoskin, Justin L.
    Sabbagh, Marwan Noel
    Al-Hasan, Yazan
    Decourt, Boris
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (06) : 545 - 554
  • [27] Tau protein and Alzheimer's disease
    Kosik, K. S.
    CURRENT OPINION IN CELL BIOLOGY, 1990, 2 (01) : 101 - 104
  • [28] Tau, Neurodegeneration and Alzheimer's Disease
    Alonso, Alejandra del Carmen
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (08) : 653 - 655
  • [29] Tau Protein in Alzheimer's Disease
    Maccioni, Ricardo B.
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (06) : 607 - 607
  • [30] Tau Ubiquitination in Alzheimer's Disease
    Li, Longfei
    Jiang, Yanli
    Wang, Jian-Zhi
    Liu, Rong
    Wang, Xiaochuan
    FRONTIERS IN NEUROLOGY, 2022, 12
12345